chrisvoncsefalvay/vaers-outcomes huggingface dataset:
She never had a heart problem before and after the vaccine she started having them.; shortness of breath; fast heartbeat; getting dizzy in the mornings when she was getting up; This spontaneous case was reported by a consumer and describes the occurrence of CARDIAC DISORDER (She never had a heart problem before and after the vaccine she started having them.), DYSPNOEA (shortness of breath), HEART RATE INCREASED (fast heartbeat) and DIZZINESS (getting dizzy in the mornings when she was getting up) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In March 2021, the patient experienced CARDIAC DISORDER (She never had a heart problem before and after the vaccine she started having them.), DYSPNOEA (shortness of breath), HEART RATE INCREASED (fast heartbeat) and DIZZINESS (getting dizzy in the mornings when she was getting up). At the time of the report, CARDIAC DISORDER (She never had a heart problem before and after the vaccine she started having them.), DYSPNOEA (shortness of breath), HEART RATE INCREASED (fast heartbeat) and DIZZINESS (getting dizzy in the mornings when she was getting up) had resolved.            Concomitant medication use was unknown. Treatment information was unknown.
Around 60 seconds after injection my left arm became heavy and tingly/numb, this then occurred in my right thumb as well.  I had a heavy sensation on my chest and my heart rate increased rapidly to over 120.  This would then resolve slowly and then the tachycardia would recur with the odd sensation over my whole body every ten-15 minutes.  EMS was called to take vitals and monitor me.  Very odd feeling.  I was monitored over the course of 2 hours and when I finally stood up my legs felt heavy and weak as well.  After going home and resting things seemed to resolve and I was even able to go out to dinner that evening.  The following week I didn't notice much of anything but new symptoms arose around 6 days later on Friday.  I would feel strange feeling in my legs and a heaviness.  I had a strange dizziness but not vertigo.  I felt like I was in slow motion at times.  This worsened and I had weakness/fatigue that reached its peak on 1/20/21 and 1/21/21.  I was unable to operate on Wednesday as an orthopedic surgeon and had to cancel cases due to this weakness.  I saw my doctor that day and had a battery of tests run.  CMP, TSH, T4, T3, COVID, COVID IgG, Epstein Barr, Brain MRI, Neruo Consult, ANA, CK, Flu A/B, Vit B12 level, ESR, CRP, Vit D level, EKG, CXR.  The following day when I awoke in the morning I felt extremely lethargic and had to cancel clinic.  Over the following weeks things have gradually improved but I occasionally get some dizzy/lightheaded moments.
Chills; FEELS AWFUL; Nausea; ARM PAIN; TIREDNESS; red puffy arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red puffy arm), NAUSEA (Nausea), LIMB DISCOMFORT (ARM PAIN), FATIGUE (TIREDNESS) and CHILLS (Chills) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 18-Feb-2021, the patient experienced ERYTHEMA (red puffy arm). On 10-Mar-2021, the patient experienced NAUSEA (Nausea), LIMB DISCOMFORT (ARM PAIN) and FATIGUE (TIREDNESS). On 28-Mar-2021, the patient experienced CHILLS (Chills) and FEELING ABNORMAL (FEELS AWFUL). On 12-Mar-2021, NAUSEA (Nausea), LIMB DISCOMFORT (ARM PAIN) and FATIGUE (TIREDNESS) had resolved. At the time of the report, ERYTHEMA (red puffy arm), CHILLS (Chills) and FEELING ABNORMAL (FEELS AWFUL) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       NO treatment or concomitant medication reported in the source document.   This case was linked to MOD-2021-061127 (Patient Link).
This spontaneous report was received from a nurse practitioner regarding a patient of an unknown age and gender. The concurrent conditions, medical history, drug allergies/reactions and concomitant medication were not provided. On 03-JAN-2019, the patient was vaccinated with M-M-R II (lot # N026828, expiration date: 27-SEP-2019) (route of administration, anatomical location, dose number were not reported). It was reported that the dose of M-M-R II was inadvertently reconstituted with a dose of MENACTRA instead of diluent. The nurse stated that the vial of MENACTRA was mistaken for a vial of diluent, but she believed the cause to be human error and not any confusion between the two products. No adverse effect reported.
urticaria/myalgias beginning 12 hrs post injection. urticaria lasted 3 days, myalgias continued for 10-14 days.  symptomatic with acetoaminphen.  note: patient had similar, but milder reaction to flu vaccine in 1998-no vaccine in 1999/2000, but has had annually since 2001 without problem until now.
This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (After his 1st dose, he was fine, he had some normal pain for a few days, after that, the aching went away, and he was fine.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (After his 1st dose, he was fine, he had some normal pain for a few days, after that, the aching went away, and he was fine). The patient was treated with PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, MYALGIA (After his 1st dose, he was fine, he had some normal pain for a few days, after that, the aching went away, and he was fine) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medications was reported. This case was linked to MOD-2021-245562 (Patient Link).
No additional AEs reported; She stated that a 9 month old patient was administered PROQUAD; This spontaneous report as received from a nurse refers to a 9-month-old patient of unknown gender. The patient's concurrent conditions, concomitant therapies and medical history was not provided.  On 08-FEB-2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live, recombinant Human albumin, (PROQUAD) 0.5 ml dose, lot # U022722, expiration date 16-JAN-2023 (route of administration and anatomical location were not reported) for prophylaxis (Product administered to patient of inappropriate age). No additional adverse events were reported (No adverse event).
Vaccine given on 6/12/23 with an expiration date of 4/24/23.
Low neutrophil count days after second vaccine. Have bene on clozapine with regular monitoring for over 11 years. I have had no issues with my neutrophil count during this time.  Received the Pfizer vaccine on a Friday and had my routine Clozapine monitoring on the following Wednesday. My neutrophils came back at 0.9. Usually they are above 1.5 and have never been a concern. A redraw of the blood work 54 hours later resulted in a normal level of neutrophils.
administration of expired moderna vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administration of expired moderna vaccine) in a 53-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administration of expired moderna vaccine). On 05-Nov-2021, EXPIRED PRODUCT ADMINISTERED (administration of expired moderna vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  The pharmacist reported about the administration of expired moderna vaccine that was given as booster shot to patient. The vaccines was stored in freezer, which was taken out one to two vials and place in fridge each day as needed.  No treatment was given on the patient.
Information has been received from a registered nurse concerning a 14 year old male who on an unspecified date was vaccinated with a dose of varicella-zoster virus instead of varicella virus vaccine.  The nurse stated that this was "probably an error on their end", she felt that the two vaccines were "clearly marked" with the vaccine names.  The patient had not had any adverse experiences.  There was no product quality complaint involved. No further information was provided.  Additional information has been requested.
The first dose made the patient wheezy; This spontaneous case was reported by a consumer and describes the occurrence of WHEEZING (The first dose made the patient wheezy) in a 67-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Blood pressure abnormal, Blood cholesterol abnormal and Thyroid disorder NOS.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced WHEEZING (The first dose made the patient wheezy). At the time of the report, WHEEZING (The first dose made the patient wheezy) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       The patient took concomitantly unspecified diabetes medication, blood pressure medication, cholesterol medication, and thyroid medication. Treatment information was not provided by the reporter.   This case was linked to MOD-2021-101739 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-Jun-2021: Vaccine start date and batch/lot # was provided.
This spontaneous report as received from a pharmacist refers to a 67 years old female patient. On 27-OCT-2014 the patient was vaccinated with ZOSTAVAX 0.65 ml, subcutaneous (lot # not reported). On unknown date in 2014 the patient developed an injection site reaction of redness and severe pain. Moreover the injection site area felt like there was a "nodule". The patient sought medical attention and the physician prescribed unspecified antibiotics as a treatment. The outcome of injection site area felt like there was a "nodule" and an injection site reaction of redness and severe pain was unknown. Relatedness between the events and ZOSTAVAX was not specified. Additional information has been requested.
mom noticed thrushing tongue motion pale writhing, vomit x 1;seen again @ clinic BP 64/40, P76, clammy, R28, gray skin tone;no LOC;soreness @ site next day ? vasovagal;no clonic/tonic motion;
REDNESS, SWELLING, HIGH TEMPERATURE. PER PATIENT PNEUMOVAX WAS GIVEN ON LEFT ARM.
low grade fever; severe muscle aches; fatigue; runny nose; wheezing cough; headache; swollen arm; weakness in extremities; nausea; blurred vision; dizziness; cough; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 10Apr2021 at 12:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included heartbeats irregular and cardiac ablation. The patient received other medications within two weeks of vaccination, names unspecified. The patient previously took codeine (MANAFACTURER UNKNOWN) from an unknown date for an unspecified indication and experienced drug allergy. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 20Mar2021 at 12:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 09:00, the patient experienced low grade fever, severe muscle aches and fatigue, runny nose, wheezing cough, headache, swollen arm, weakness in extremities, nausea, blurred vision, dizziness. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events low grade fever, severe muscle aches and fatigue, runny nose, wheezing cough, headache, swollen arm, weakness in extremities, nausea, blurred vision, dizziness was recovering.  No follow-up attempts are needed. No further information is expected.
Post menopausal bleeding.   Spotting day after vax  (9/15/21) Heavy bleeding and cramps day two (9/16/21)
death;autopsy consistent w/SIDS;12-14 hr yawning-nodding;
Patient received 2nd dose of primary series too soon.  First dose of primary series with Moderna COVID-19 vaccine on 6/2/22, and second dose of Moderna COVID-19 vaccine received on 6/21/22.
Headaches; Nausea; This is a spontaneous report  from a contactable consumer, the patient. A 45-year-old  male patient received first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6198)  via an unspecified route of administration in the right arm, on 09Mar2021 at 12:00 (at the age of 45-years-old) as a single dose for COVID-19 immunisation. The patient had a medical history of diabetes, blood pressure high (high blood pressure) and high cholesterol. Concomitant medications include simvastatin  (MANUFACTURER UNKNOWN), hydrochlorothiazide  (MANUFACTURER UNKNOWN), glipizide (MANUFACTURER UNKNOWN) and metfor (MANUFACTURER UNKNOWN). The patient had no allergy to medications, food, or other products. The patient had not received any vaccine within four weeks prior to the COVID-19 vaccine. Prior to vaccination and since the vaccination the patient had not been diagnosed with COVID-19. On 14Mar2021,the  patient experienced headache and nausea.  The patient had not received any therapeutic measure or treatment taken for the resulted adverse event. The clinical outcome of headache and nausea was not resolved. No follow-up attempts are needed. No further information is expected.
swelling under left eye; fever; headache; soreness in the lymph node area on left side; This spontaneous case was reported by a consumer and describes the occurrence of EYE SWELLING (swelling under left eye), PYREXIA (fever), HEADACHE (headache) and LYMPH NODE PAIN (soreness in the lymph node area on left side) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced LYMPH NODE PAIN (soreness in the lymph node area on left side). On 31-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EYE SWELLING (swelling under left eye), PYREXIA (fever) and HEADACHE (headache). At the time of the report, EYE SWELLING (swelling under left eye), PYREXIA (fever), HEADACHE (headache) and LYMPH NODE PAIN (soreness in the lymph node area on left side) outcome was unknown.            No relevant concomitant medication was reported. Treatment information was not provided.   This case was linked to MOD-2021-065885 (Patient Link).
Patient stated about 3 hours after receiving flu vaccine developed shortness of breath, wheezing and a rash on his abdomen and chest. The above is a physician and he self treated with a nembulizer treatment which improved respiratory symptoms. The rash persisted for 1-2 weeks.
Woke up frontal forehead and crown of my head (top crown) to top of eyebrows headache; I hadn't experienced anything like it before - like a deck of books was on it. Lasted a whole day into the next morning. I didn't take anything. My neck hurt severely - like I had injured it - but there was no reason for it to hurt. That lasted a few days. My jaw was a little sore, as well. I had ringing in my ears (not sure if it's in both ears or not; I can't tell) - that has been constant since then and has not gone away. 3-14-2021 - went to physical and then went to doctor for the ringing of ear. That symptom is still continuing. I do have a follow up visit scheduled with the doctor.
Report 2001026536-1 describes confusion in an 18 yr old female who received an injection of hepatitis B vaccine recombinant (Engerix-B). Medical history, concurrent conditions, and concurrent medications were not specified. On 9/12/01, the vaccinee received her first injection of Engerix B. On 9/12/01, at an unspecified time post vaccination, the vaccinee experienced confusion, a headache and chills. She was seen in the emergency department for the events. The reporter indicated the events resolved.
I was extremely tired the first day. The next morning my kidneys were really hurting, especially my left one. It had been damaged in a previous surgery. It has been hurting since the vaccine quite a bit. I went to see my urologist yesterday and he said that if it continued more than a couple of weeks then he would like to do a CAT scan. They did not give me any medications. They did an x-ray on Wednesday, the day before I saw my doctor. The x-ray came back normal.
Torso red, itchy rash.  Rash also noted around administration area.  Took Benadryl.
very itchy rash on legs; burning on legs; needly sensation on legs; raised bumps at the injection site; Bull's eye rash at the injection site; painful at the injection site; itchy at the injection site; small red spot at the injection site/red at the injection site; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH PRURITIC (very itchy rash on legs), BURNING SENSATION (burning on legs), PARAESTHESIA (needly sensation on legs), VACCINATION SITE PAPULE (raised bumps at the injection site) and INJECTION SITE RASH (Bull's eye rash at the injection site) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concurrent medical conditions included Environmental allergy. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (small red spot at the injection site/red at the injection site). On 27-Jan-2021, the patient experienced VACCINATION SITE PAPULE (raised bumps at the injection site), INJECTION SITE RASH (Bull's eye rash at the injection site), VACCINATION SITE PAIN (painful at the injection site) and INJECTION SITE PRURITUS (itchy at the injection site). On 31-Jan-2021, the patient experienced RASH PRURITIC (very itchy rash on legs), BURNING SENSATION (burning on legs) and PARAESTHESIA (needly sensation on legs). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency; FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency and TRIAMCINOLONE ACETONIDE at an unspecified dose and frequency. On 02-Feb-2021, VACCINATION SITE PAPULE (raised bumps at the injection site), INJECTION SITE RASH (Bull's eye rash at the injection site), INJECTION SITE ERYTHEMA (small red spot at the injection site/red at the injection site), VACCINATION SITE PAIN (painful at the injection site) and INJECTION SITE PRURITUS (itchy at the injection site) had resolved. At the time of the report, RASH PRURITIC (very itchy rash on legs), BURNING SENSATION (burning on legs) and PARAESTHESIA (needly sensation on legs) outcome was unknown. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Influenza immunization given Left Deltoid at event. Had pain at injection site that evening. Redness and itching, edema with 6cm of injection site.
Swollen lymph nodes under armpit of injection; dull headache; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: ek873c), via an unspecified route of administration in the left arm on 30Mar2021 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and high cholesterol. The patient did not have any allergies to medications, food, or other products. The patient did not receive any medications within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA Vaccine; Lot number: ENGZ06), via an unspecified route of administration in the left arm on 09Mar2021 at 10:00 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 31Mar2021 at 15:00, +30hrs after second shot, the patient experienced swollen lymph nodes under armpit of injection site and dull headache. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the events swollen lymph nodes under armpit of injection site and dull headache was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
In September 2021 suffered a Pulmonary Embolism. Had a blood clot in each lung. Was diagnosed with the PE after going to ER on 09/25/2021.
pain arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (pain arm). At the time of the report, VACCINATION SITE PAIN (pain arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
High bp  Severe headache  Nose bleeds  Started with in 20 minutes of vaccine.  High bp and headaches continue since vax.  daily issue